Gynae and Obs
12th June 2026, NIA Diagnostic Imaging
Intrauterine contraceptive device (IUCD) is a common form of contraception. We are all familiar with the Mirena. There may be many occasions where we may to assess the location of the device and it can be easily done with a pelvic ultrasound. There may be other reasons why we may to assess the device.…
10th June 2026, A/Prof Chee L Khoo
We know that if a woman developed gestational diabetes mellitus (GDM), the risk of development of type 2 diabetes (T2D) later in life increases by 4-10 times. We also know that the same woman also have higher risk of developing elements of cardiovascular disease (CVD) including hypertension, atherosclerotic CVD ASCVD and heart failure (HF).…
28th March 2026, A/Prof Chee L Khoo
Not all women with gestational diabetes mellitus (GDM) are the same. There are three subtypes of GDM – isolated fasting hyperglycaemia, isolated post prandial hyperglycaemia or combination of both being abnormal. Similarly, not all women with GDM end up the same after delivery. Women with GDM are recommended to have an OGTT at the 6 weeks postpartum.…
3rd January 2026, A/Prof Chee L Khoo
Women, in general, have a lower cardiovascular (CV) risk because of the “protection” from the oestrogen exposure from puberty onwards. Of course, that “protection” ends when a woman becomes menopausal and indeed, the prevalence of CV events very quickly approaches those of men within a few years. One of the most difficult decisions to make is when to treat elevated lipids in women.…
14th October 2025, NIA Diagnostic Imaging
Breast cancer is a major public health issue. It is the most common cancer in Australian women and the second most common cancer overall (Breast Cancer Network Australia, n.d.). Breast markers (or clips) are small (2–3 mm) biocompatible metallic or bioabsorbable markers placed in a breast lesion or area of abnormality. These markers provide a permanent visual reference (unless removed during surgery) for certain procedures and for correlation with imaging across different modalities.…
30th June 2025, A/Prof Chee L Khoo
You would have no doubt noticed headlines everywhere about the new criteria for GDM diagnosis that was just released a few days ago. Why is there such a buzz? Why is everyone seemingly that excited? We have covered many of the issues covered by ADIPS over the years leading up to this new guideline.…
12th April 2025, NIA Diagnostic Imaging
Uterine fibroids, also referred to as leiomyomas, are the most prevalent benign tumors in women of reproductive age, originating from smooth muscle cells in the uterus (myometrium) (1). While benign, uterine fibroids can greatly affect a woman’s daily quality of life (4). Ultrasound is the first-line modality used for diagnosing and characterising these fibroids (5).…
23rd March 2025, A/Prof Chee L Khoo
I thought I read somewhere many years ago that we don’t have to advocate the traditional 72-hour carbohydrate (carb) loading prior to an oral glucose tolerance test (OGTT). I have not heard that issue being brought up of late. Well, does it increase or decrease the glucose levels of the OGTT.…
10th February 2025, A/Prof Chee L Khoo
We perform cardiovascular (CV) risk assessments in our consulting rooms everyday. We assess lipid profiles, smoking history, family history and activity levels in our patients routinely and try to quantify the likelihood they may have a cardiovascular event. Over the years at GPVoice we have tried to expand beyond the traditional risk factors as more data come to hand.…
12th December, NIA Diagnostic Imaging
We know that screening mammography is not perfect. This is particularly the case in breasts that are dense. Breast tissue density is a predictor of breast cancer (BC) risk (1-3). Pooled analyses have shown a fourfold to fivefold increase in BC risk for women with the highest breast tissue density compared with those classified in the lowest density category, independently of other risk factors for BC that may be present in women with high breast density (1,3).…
29th November 2024, A/Prof Chee L Khoo
We have written a bit on the paradigm change in our diagnosis and management of GDM over the last couple of years. We have looked at the TOBOGM study at length about early GDM (eGDM). This is GDM diagnosed before 24-week gestation. The TOBOGM study demonstrated that it is important to diagnosed early GDM as early treatment significantly improve neonatal and maternal outcomes.…
13th October 2024, NIA Diagnostic Imaging
Menopause is characterised by complete absence of menstrual cycle due to no ovarian follicles left in reserve and it is clinically diagnosed when a woman has amenorrhea for at least 1 year (Sung, 2023).
Any post-menopausal women with vaginal bleeding should be appropriately managed through comprehensive clinical examinations and diagnostic studies; these include diagnostic imaging and, in some cases, endometrial biopsies (Sung, 2023).…